Bioqual Operating Margin 2010-2024 | BIOQ
Current and historical operating margin for Bioqual (BIOQ) over the last 10 years. The current operating profit margin for Bioqual as of November 30, 2024 is -4.34%.
| Bioqual Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-11-30 |
$0.05B |
$-0.01B |
-10.00% |
| 2024-08-31 |
$0.06B |
$0.00B |
-3.64% |
| 2024-05-31 |
$0.06B |
0 |
0.00% |
| 2024-02-29 |
$0.06B |
$0.00B |
1.59% |
| 2023-11-30 |
$0.06B |
$0.00B |
-1.61% |
| 2023-08-31 |
$0.06B |
0 |
0.00% |
| 2023-05-31 |
$0.06B |
$0.00B |
1.59% |
| 2023-02-28 |
$0.07B |
$0.00B |
6.15% |
| 2022-11-30 |
$0.07B |
$0.01B |
10.29% |
| 2022-08-31 |
$0.07B |
$0.01B |
10.61% |
| 2022-05-31 |
$0.07B |
$0.01B |
10.77% |
| 2022-02-28 |
$0.06B |
$0.01B |
12.50% |
| 2021-11-30 |
$0.06B |
$0.01B |
13.33% |
| 2021-08-31 |
$0.06B |
$0.01B |
13.56% |
| 2021-05-31 |
$0.06B |
$0.01B |
13.56% |
| 2021-02-28 |
$0.06B |
$0.00B |
3.64% |
| 2020-11-30 |
$0.05B |
$0.00B |
3.70% |
| 2020-08-31 |
$0.05B |
$0.00B |
1.96% |
| 2020-05-31 |
$0.05B |
$0.00B |
2.17% |
| 2020-02-29 |
$0.05B |
$0.02B |
35.56% |
| 2019-11-30 |
$0.04B |
$0.02B |
37.21% |
| 2019-08-31 |
$0.04B |
$0.02B |
40.00% |
| 2019-05-31 |
$0.04B |
$0.02B |
60.00% |
| 2019-02-28 |
$0.04B |
$0.02B |
57.89% |
| 2018-11-30 |
$0.04B |
$0.03B |
80.56% |
| 2018-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2018-05-31 |
$0.04B |
$0.04B |
100.00% |
| 2018-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2017-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2017-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2017-05-31 |
$0.04B |
$0.04B |
100.00% |
| 2017-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2016-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2016-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2016-05-31 |
$0.03B |
$0.03B |
100.00% |
| 2016-02-29 |
$0.03B |
$0.03B |
100.00% |
| 2015-11-30 |
$0.03B |
$0.03B |
100.00% |
| 2015-08-31 |
$0.03B |
$0.03B |
100.00% |
| 2015-05-31 |
$0.03B |
$0.03B |
100.00% |
| 2015-02-28 |
$0.03B |
$0.03B |
100.00% |
| 2014-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2014-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2013-11-30 |
$0.02B |
$0.02B |
100.00% |
| 2013-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2013-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2012-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2012-02-29 |
$0.02B |
$0.02B |
100.00% |
| 2011-11-30 |
$0.02B |
$0.02B |
100.00% |
| 2011-08-31 |
$0.02B |
$0.02B |
100.00% |
| 2011-05-31 |
$0.02B |
$0.02B |
100.00% |
| 2011-02-28 |
$0.04B |
$0.04B |
100.00% |
| 2010-11-30 |
$0.04B |
$0.04B |
100.00% |
| 2010-08-31 |
$0.04B |
$0.04B |
100.00% |
| 2010-05-31 |
$0.04B |
$0.04B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.049B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
